3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Uterine Cervical Dysplasia
1
Thrombocythemia, Essential
1
Rectal Neoplasms
1
Psychological Well-Being
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Neurofibromatosis 1
1
Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lung Neoplasms
1
Joint Diseases
1
Gastritis, Atrophic
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Castration Sensitive Prostate Cancer
1
Breast Neoplasms
1
Arthralgia
1
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
24
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
cemiplimab
6
atezolizumab
6
Radiation
6
Chemoradiotherapy
6
toripalimab
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Curcumin
×
1 year
×
Clear all
No trials found.